129 filings
Page 2 of 7
8-K
rk7vj2toffw
27 Jun 23
Departure of Directors or Certain Officers
5:05pm
8-K
r5vjxve
23 Jun 23
Entry into a Material Definitive Agreement
4:41pm
424B5
u88c0i5ar
23 Jun 23
Prospectus supplement for primary offering
4:35pm
FWP
y7im dfro
22 Jun 23
Free writing prospectus
8:09am
424B5
r33fzzo 9mn38
22 Jun 23
Prospectus supplement for primary offering
6:19am
FWP
3pnh nresqa
21 Jun 23
Free writing prospectus
7:00pm
8-K
b1fds zqzyl6fus6y
21 Jun 23
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
4:59pm
8-K
1luo5b 76a
12 May 23
IGM Biosciences Announces First Quarter 2023 Financial Results and Provides Corporate Update
9:06am
ARS
qfpwg3 kj
27 Apr 23
Annual report to shareholders
4:35pm
DEFA14A
8kviql ihbcsa376vz
27 Apr 23
Additional proxy soliciting materials
4:32pm
S-8
rad1ghep5z
30 Mar 23
Registration of securities for employees
4:11pm
8-K
bdr4 db1be07p4fcsy
30 Mar 23
IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
4:06pm
8-K
u2x4b272r2c3290
21 Mar 23
Amendments to Articles of Incorporation or Bylaws
4:15pm
8-K
peqero44ks3
10 Mar 23
Regulation FD Disclosure
4:22pm
8-K
zvnjh 9nv
6 Jan 23
Results of Operations and Financial Condition
5:15pm
EFFECT
g1bgw4y
15 Nov 22
Notice of effectiveness
12:15am
UPLOAD
dehxbs2vx2 rsaklb
9 Nov 22
Letter from SEC
12:00am